Daiichi Sankyo Sustainability Profile
Daiichi Sankyo Company, Limited, commonly referred to as Daiichi Sankyo, is a prominent global pharmaceutical firm headquartered in Tokyo, Japan. Founded in 1899, the company has established a strong presence in major operational regions, including North America, Europe, and Asia, focusing on innovative healthcare solutions. Specialising in the research, development, and manufacturing of pharmaceuticals, Daiichi Sankyo is particularly renowned for its contributions to oncology, cardiovascular, and vaccine development. The company’s unique approach combines cutting-edge science with a commitment to improving patient outcomes, positioning it as a leader in the pharmaceutical industry. With a rich history marked by key milestones, Daiichi Sankyo has achieved notable success, including the development of groundbreaking therapies that have transformed treatment paradigms. Its dedication to innovation and quality has solidified its reputation as a trusted name in healthcare worldwide.
DitchCarbon Score
How does Daiichi Sankyo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Daiichi Sankyo's score of 67 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Daiichi Sankyo's reported carbon emissions
In 2024, Daiichi Sankyo reported total carbon emissions of approximately 4,274,477,000 kg CO2e, with Scope 1 emissions at about 89,118,000 kg CO2e, Scope 2 emissions at approximately 24,888,000 kg CO2e, and a significant contribution from Scope 3 emissions, which totalled around 4,160,471,000 kg CO2e. This indicates a continued reliance on indirect emissions, primarily from purchased goods and services. For the previous year, 2023, the company recorded total emissions of about 4,517,975,000 kg CO2e globally, with Scope 1 emissions at approximately 85,245,000 kg CO2e and Scope 2 emissions at around 23,994,000 kg CO2e. The Scope 3 emissions for that year were about 4,408,736,000 kg CO2e, highlighting the substantial impact of their supply chain and product lifecycle. Daiichi Sankyo has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions by FY2050. This long-term goal includes a near-term target to reduce absolute Scope 1 and 2 emissions by 63% by FY2030 from a FY2015 baseline. Additionally, the company plans to increase its sourcing of renewable electricity from 4% in FY2015 to 100% by FY2030. Furthermore, they aim for 70.6% of their suppliers, by emissions, to have science-based targets by FY2025. These targets are part of their broader strategy to align with the Science Based Targets initiative (SBTi) and the goals of the Paris Agreement, demonstrating a commitment to sustainable practices within the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 182,519,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 290,715,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 5,704,000 | - | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Daiichi Sankyo's Industry?
How Carbon Intensive is Daiichi Sankyo's Location?
Daiichi Sankyo's Scope 3 Categories Breakdown
Daiichi Sankyo's Scope 3 emissions, which decreased by 6% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 85% of Scope 3 emissions.
Top Scope 3 Categories
Daiichi Sankyo's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Daiichi Sankyo has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
